Company / Assets per Share
Acadia Pharmaceuticals Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$9.38
FY2025
5-year range
$3.65 / $9.38
FY2021-FY2025
Trend
+30.1%
vs FY2024
Sector context
#103 of 210
Health Care
What the data says
At $9.38, Acadia Pharmaceuticals's assets per share ranks #103 of 210 in the Health Care sector. Assets per Share has increased for 3 consecutive years, from $3.65 in FY2022 to $9.38 in FY2025.
Based on SEC 10-K filings.
9.38 in FY2025 with a 5-year CAGR of +13.2%.
Improved from $4.62 to $9.38 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +37.0%
- 5-Year CAGR
- +13.2%
- 10-Year CAGR
- -
Sector benchmark
#103 of 210 in Health CareTop 49% of 210This company $9.38 Sector average $296.79
▼
-96.8% below sector average
Key checks
Key Insights
- Acadia Pharmaceuticals's assets per share has grown for 3 consecutive years.
- In FY2025, assets per share increased 30.1% year-over-year.
- Ranks #103 out of 210 companies in the Health Care sector.
- Lowest assets per share in the period was in FY2017.
Company context
Key Data Points
- Strong profit margin: 24.9%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 28.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.38 | +30.1% |
| FY2024 | $7.21 | +56.1% |
| FY2023 | $4.62 | +26.6% |
| FY2022 | $3.65 | -16.8% |
| FY2021 | $4.39 | -13.0% |
| FY2020 | $5.04 | -7.4% |
| FY2019 | $5.44 | +25.4% |
| FY2018 | $4.34 | +37.1% |
| FY2017 | $3.17 | -42.4% |
| FY2016 | $5.50 | +148.2% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026